Conversely, the overexpression or activation of SESN2 has been shown to counteract metabolic dysfunction and protect against diet-induced obesity and insulin resistance by modulating AMP-activated protein kinase (AMPK) and mammalian target of rapamycin (mTOR) pathways (8). This evidence concerns the gene MTOR and obesity disorder.